drugset / Press release
LUPKYNIS Associated with a Statistically Significant 53% Reduction in Risk of Renal-Related Event or Death
2026-06-04 · Aurinia Pharmaceuticals Inc. · original auriniapharma.com ↗
—New Analysis of the AURORA 1 Phase 3 Study Presented at EULAR 2026 Congress—
The release as fetched from its publisher. auriniapharma.com ↗